{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T18:41:46Z","timestamp":1720291306257},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.diagmicrobio.2003.10.013","type":"journal-article","created":{"date-parts":[[2004,1,22]],"date-time":"2004-01-22T10:19:43Z","timestamp":1074766783000},"page":"283-286","source":"Crossref","is-referenced-by-count":12,"title":["Concentrations of moxifloxacin in serum and synovial fluid, and ex vivo bactericidal activity against arthritis-causing pathogens"],"prefix":"10.1016","volume":"48","author":[{"given":"M","family":"Dan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Keynan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Feldbrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Poch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00003495-199957030-00007","article-title":"Moxifloxacin","volume":"57","author":"Barman Balfour","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/AEM.14.2.170-177.1966","article-title":"Simplified accurate method for antibiotic assay of clinical specimens","volume":"14","author":"Bennet","year":"1966","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB3","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1128\/AAC.45.11.3076-3083.2001","article-title":"Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance","volume":"45","author":"Entanza","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/infdis\/129.2.187","article-title":"Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections","volume":"129","author":"Klastersky","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB5","doi-asserted-by":"crossref","unstructured":"Lister, P. D. (2001) Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmocokinetic model. Clin Infect Dis 32 (Suppl. 1), S33\u2013S38","DOI":"10.1086\/319374"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB6","doi-asserted-by":"crossref","unstructured":"Muller\u2013Serieys, C., Delrre, D., Benoit, C., Bigot, C., Maubert, Carbon, C. (1999) Levofloxacin: serum bactericidal activity against methicillin-resistant staphylococcal isolates. J Antimicrob Chemother 43 (Suppl. C), 67\u201370","DOI":"10.1093\/jac\/43.suppl_3.67"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB7","unstructured":"National Committee for Clinical Laboratory Standards. (1999) Methodology for Serum Bactericidal Tests. M21-A. NCCLS, Villanova, PA"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB8","unstructured":"National Committee for Clinical Laboratory Standards. (2002) Performance Stands for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. M100-S12. NCCLS, Villanova, PA"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB9","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/AAC.46.6.2046-2048.2002","article-title":"Pharmacodynamics of moxifloxacin against Streptococcus pyogenes in an in vitro kinetic model","volume":"46","author":"Odenholt","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.279.2.125","article-title":"Pharmacodynamics of levofloxacin","volume":"279","author":"Preston","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB11","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/AAC.45.11.3092-3097.2001","article-title":"Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis","volume":"45","author":"Rodriguez\u2013Cerrato","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2003.10.013_BIB12","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1086\/319375","article-title":"What have we learned from pharmacokinetic and pharmacodynamic theories","volume":"32","author":"Schentag","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0002-9343(85)90436-X","article-title":"Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis","volume":"78","author":"Weinstein","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0002-9343(87)90688-7","article-title":"Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis","volume":"83","author":"Weinstein","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00044011-199917050-00004","article-title":"A review of the clinical pharmacology of moxifloxacin, a new 8-methoxyquinolone, and its potential relation to therapeutic efficacy","volume":"17","author":"Wise","year":"1999","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.diagmicrobio.2003.10.013_BIB16","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJM198504113121507","article-title":"Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy","volume":"312","author":"Wolfson","year":"1985","journal-title":"N Engl J Med"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889303002402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889303002402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T06:17:19Z","timestamp":1585462639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889303002402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0732889303002402"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2003.10.013","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}